Short answer
SANUWAVE Health, Inc. (SNWV) filed its Q2 2026 10-Q quarterly report on Aug 6, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $10M (down 4.2% year over year) with net income of −$682,000.
Q2 2026 key financials · XBRL
- Revenue
- $10M
- −4.2% YoY · +1.2% QoQ
- Net income
- −$682,000
- −164.6% YoY · +52.6% QoQ
- Operating margin
- -2.9%
- Gross margin
- 76.2%
- EPS (diluted)
- −$0.08
- −166.7% YoY · +52.9% QoQ
Source: XBRL data from the SANUWAVE Health, Inc. (SNWV) Q2 2026 10-Q on SEC EDGAR. USD.
SANUWAVE Health, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $9.739M, down 3% YoY from $10.054M
- Gross margin 76% vs 78% YoY; operating loss $0.280M vs income $1.438M
- Consumables revenue $7.3M, up 12%; UltraMIST® systems $2.3M, down 34%
- Cash $9.4M; operating cash flow $0.822M vs use of $0.524M YoY
- $2.9M term-loan principal payments; weaker capital sales and elevated inflation headwinds
Risk Factors
- Equity issuance risk: 4,000 common shares issued to Big Vision Ventures LLC as consultant compensation
- Securities-law compliance risk: reliance on Securities Act Section 4(a)(2) registration exemption
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other SANUWAVE Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.